DAVENPORT & Co LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 136 filers reported holding CARA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.82 and the average weighting 0.5%.

Quarter-by-quarter ownership
DAVENPORT & Co LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$135,920,000
-17.9%
10,979
-18.8%
0.00%0.0%
Q4 2017$165,595,000
-14.3%
13,529
-4.1%
0.00%0.0%
Q3 2017$193,180,000
-65.8%
14,111
-61.6%
0.00%
-71.4%
Q2 2017$565,229,000
+179.9%
36,727
+69.0%
0.01%
+133.3%
Q1 2017$201,936,000
+100365.7%
21,7370.0%0.00%0.0%
Q4 2016$201,000
-99.9%
21,737
+1.7%
0.00%0.0%
Q3 2016$178,497,00021,3770.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,193,057$51,440,00039.10%
Chescapmanager LLC 1,299,701$20,938,0003.08%
Burrage Capital Management LLC 284,170$4,578,0003.07%
Cypress Capital Management LLC (WY) 184,085$2,966,0002.80%
DAFNA Capital Management LLC 328,533$5,293,0001.82%
Mesirow Financial Investment Management, Inc. 21,169$341,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 471,575$7,597,0001.14%
AdvisorShares Investments LLC 79,821$1,286,0000.80%
ETF MANAGERS GROUP, LLC 750,680$12,093,0000.42%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$37,053,0000.25%
View complete list of CARA THERAPEUTICS INC shareholders